• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O2-芳基双叠氮二酸盐“双 JS-K”介导的交联蛋白谷胱甘肽化。

Cross-linking protein glutathionylation mediated by O2-arylated bis-diazeniumdiolate "Double JS-K".

机构信息

Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.

出版信息

Chem Res Toxicol. 2012 Dec 17;25(12):2670-7. doi: 10.1021/tx3003142. Epub 2012 Nov 9.

DOI:10.1021/tx3003142
PMID:23106594
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3524378/
Abstract

Attachment of glutathione (GSH) to cysteine residues in proteins (S-glutathionylation) is a reversible post-translational modification that can profoundly alter protein structure and function. Often serving in a protective role, for example, by temporarily saving protein thiols from irreversible oxidation and inactivation, glutathionylation can be identified and semiquantitatively assessed using anti-GSH antibodies, thought to be specific for recognition of the S-glutathionylation modification. Here, we describe an alternate mechanism of protein glutathionylation in which the sulfur atoms of the GSH and the protein's thiol group are covalently bound via a cross-linking agent, rather than through a disulfide bond. This form of thiol cross-linking has been shown to occur and has been confirmed by mass spectrometry at the solution chemistry level, as well as in experiments documenting the potent antiproliferative activity of the bis-diazeniumdiolate Double JS-K in H1703 cells in vitro and in vivo. The modification is recognized by the anti-GSH antibody as if it were authentic S-glutathionylation, requiring mass spectrometry to distinguish between them.

摘要

谷胱甘肽(GSH)与蛋白质半胱氨酸残基的结合(S-谷胱甘肽化)是一种可逆的翻译后修饰,可以深刻改变蛋白质的结构和功能。例如,它通常具有保护作用,通过暂时保存蛋白质巯基免受不可逆氧化和失活,谷胱甘肽化可以使用抗 GSH 抗体进行识别和半定量评估,这些抗体被认为是特异性识别 S-谷胱甘肽化修饰的。在这里,我们描述了一种蛋白质谷胱甘肽化的替代机制,其中 GSH 的硫原子和蛋白质的巯基通过交联剂共价结合,而不是通过二硫键。这种形式的硫交联已被证明在溶液化学水平以及在实验中发生,并通过质谱证实,实验记录了双氮烯二醇 Double JS-K 在体外和体内 H1703 细胞中的强大抗增殖活性。该修饰被抗 GSH 抗体识别为真实的 S-谷胱甘肽化,需要通过质谱来区分它们。

相似文献

1
Cross-linking protein glutathionylation mediated by O2-arylated bis-diazeniumdiolate "Double JS-K".O2-芳基双叠氮二酸盐“双 JS-K”介导的交联蛋白谷胱甘肽化。
Chem Res Toxicol. 2012 Dec 17;25(12):2670-7. doi: 10.1021/tx3003142. Epub 2012 Nov 9.
2
Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance.释放一氧化氮的前药通过破坏细胞氧化还原平衡引发癌细胞死亡。
Redox Biol. 2013 Feb 1;1(1):115-24. doi: 10.1016/j.redox.2012.12.002. eCollection 2013.
3
Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs.谷胱甘肽/谷胱甘肽S-转移酶激活的一氧化氮前药的合成、机理研究及抗增殖活性
Bioorg Med Chem. 2008 Nov 15;16(22):9764-71. doi: 10.1016/j.bmc.2008.09.063. Epub 2008 Sep 30.
4
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity.JS-K,一种二氮烯二醇盐类的谷胱甘肽/谷胱甘肽S-转移酶激活的一氧化氮供体,具有强大的抗肿瘤活性。
Mol Cancer Ther. 2003 Apr;2(4):409-17.
5
Structural modifications modulate stability of glutathione-activated arylated diazeniumdiolate prodrugs.结构修饰调节谷胱甘肽激活的芳基偶氮二氮烯醇前药的稳定性。
Bioorg Med Chem. 2012 May 1;20(9):3094-9. doi: 10.1016/j.bmc.2012.02.045. Epub 2012 Mar 9.
6
The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species.一氧化氮前体药物 JS-K 对体外和体内非小细胞肺癌细胞有效:涉及活性氧物种。
J Pharmacol Exp Ther. 2011 Feb;336(2):313-20. doi: 10.1124/jpet.110.174904. Epub 2010 Oct 20.
7
JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.JS-K,一种谷胱甘肽 S-转移酶激活的一氧化氮供体,具有恶性神经胶质瘤的抗肿瘤活性。
Neurosurgery. 2012 Feb;70(2):497-510; discussion 510. doi: 10.1227/NEU.0b013e31823209cf.
8
Synthesis and in vitro anti-leukemic activity of structural analogues of JS-K, an anti-cancer lead compound.抗癌先导化合物JS-K的结构类似物的合成及其体外抗白血病活性
Bioorg Med Chem Lett. 2008 Feb 1;18(3):950-3. doi: 10.1016/j.bmcl.2007.12.044. Epub 2008 Jan 4.
9
Glutathionylation of beta-actin via a cysteinyl sulfenic acid intermediary.通过半胱氨酰亚磺酸中间体对β-肌动蛋白进行谷胱甘肽化修饰。
BMC Biochem. 2007 Dec 10;8:26. doi: 10.1186/1471-2091-8-26.
10
Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.O2-(2,4-二硝基苯基)重氮氨基醇和齐墩果酸的杂交分子:一种谷胱甘肽 S-转移酶 π 激活的一氧化氮前药,具有选择性的抗人肝癌活性和提高的稳定性。
J Med Chem. 2013 Jun 13;56(11):4641-55. doi: 10.1021/jm400393u. Epub 2013 May 16.

引用本文的文献

1
A comparison of reversible versus irreversible protein glutathionylation.可逆与不可逆蛋白质谷胱甘肽化的比较。
Adv Cancer Res. 2014;122:177-98. doi: 10.1016/B978-0-12-420117-0.00005-0.
2
Nitric oxide (NO) releasing poly ADP-ribose polymerase 1 (PARP-1) inhibitors targeted to glutathione S-transferase P1-overexpressing cancer cells.一氧化氮(NO)释放多聚 ADP-核糖聚合酶 1(PARP-1)抑制剂靶向谷胱甘肽 S-转移酶 P1 过表达的癌细胞。
J Med Chem. 2014 Mar 27;57(6):2292-302. doi: 10.1021/jm401550d. Epub 2014 Feb 25.

本文引用的文献

1
JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.JS-K,一种谷胱甘肽 S-转移酶激活的一氧化氮供体,具有恶性神经胶质瘤的抗肿瘤活性。
Neurosurgery. 2012 Feb;70(2):497-510; discussion 510. doi: 10.1227/NEU.0b013e31823209cf.
2
Polyamines are traps for reactive intermediates in furan metabolism.多胺是呋喃代谢中活性中间体的陷阱。
Chem Res Toxicol. 2011 Nov 21;24(11):1924-36. doi: 10.1021/tx200273z. Epub 2011 Sep 12.
3
S-glutathionylation: from molecular mechanisms to health outcomes.S-谷胱甘肽化:从分子机制到健康结果。
Antioxid Redox Signal. 2011 Jul 1;15(1):233-70. doi: 10.1089/ars.2010.3540. Epub 2011 May 25.
4
The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species.一氧化氮前体药物 JS-K 对体外和体内非小细胞肺癌细胞有效:涉及活性氧物种。
J Pharmacol Exp Ther. 2011 Feb;336(2):313-20. doi: 10.1124/jpet.110.174904. Epub 2010 Oct 20.
5
Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles.通过将前体药物和抗癌先导物 PABA/NO 和 Double JS-K 整合到聚乙二醇保护的纳米粒子中,实现其稳定。
Mol Pharm. 2010 Feb 1;7(1):291-8. doi: 10.1021/mp900245h.
6
Covalent cross-linking of glutathione and carnosine to proteins by 4-oxo-2-nonenal.4-氧代-2-壬烯醛使谷胱甘肽和肌肽与蛋白质发生共价交联。
Chem Res Toxicol. 2009 Jun;22(6):1050-9. doi: 10.1021/tx9000144.
7
Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities.芳基双(重氮二醇盐):细胞蛋白S-谷胱甘肽化的强效诱导剂及其体外抗增殖活性。
J Med Chem. 2008 Dec 25;51(24):7944-52. doi: 10.1021/jm800831y.
8
Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.可逆性蛋白质S-谷胱甘肽化修饰的分子机制及临床意义
Antioxid Redox Signal. 2008 Nov;10(11):1941-88. doi: 10.1089/ars.2008.2089.
9
Redox regulation of the protein tyrosine phosphatase PTP1B in cancer cells.癌细胞中蛋白酪氨酸磷酸酶PTP1B的氧化还原调节
FEBS J. 2008 Jan;275(1):69-88. doi: 10.1111/j.1742-4658.2007.06173.x. Epub 2007 Dec 6.
10
Glutathionylation pathways in drug response.药物反应中的谷胱甘肽化途径。
Curr Opin Pharmacol. 2007 Aug;7(4):398-403. doi: 10.1016/j.coph.2007.04.006. Epub 2007 Jul 3.